Papaverină Arena (Papaverine Hydrochloride)

Papaverine Hydrochloride, the active ingredient in Papaverină Arena, is a smooth‑muscle relaxant presented as a sterile injectable solution for intravenous use. It is employed to alleviate spasm of smooth muscle in certain vascular and gastrointestinal procedures. GNH USA supplies Papaverină Arena as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

GNH USA supplies Papaverină Arena as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

Papaverine is used primarily for its vasodilatory and smooth‑muscle relaxing actions in several clinical contexts.

- Coronary artery spasm: Relieves the spasm and improves blood flow during cardiac catheterisation. - Gastrointestinal spasm: Reduces muscle tone in the gastrointestinal tract during endoscopic procedures. - Peripheral vascular spasm: Helps dilate peripheral vessels to improve perfusion during diagnostic angiography. - Erectile dysfunction (rare off‑label use): May facilitate local vasodilation when administered intra‑arterially.

Papaverine may cause a range of adverse reactions, most of which are dose‑dependent and reversible.

Common Side Effects: - Flushing - Headache - Nausea - Dizziness - Hypotension - Mild abdominal discomfort

Serious or Rare Side Effects: - Severe hypotension - Cardiac arrhythmias - Hepatic dysfunction - Allergic anaphylaxis - Local injection site necrosis

When using Papaverine, clinicians should consider several safety measures.

- Contraindication: Patients with known hypersensitivity to papaverine or its excipients. - Cardiovascular monitoring: Observe for significant blood‑pressure drops and arrhythmias. - Liver function: Assess baseline hepatic enzymes in patients with liver disease. - Pregnancy: Use only if clearly beneficial to the mother and fetus under specialist guidance. - Breastfeeding: Caution as the drug may enter milk; weigh benefits against risks. - Store at below 25°C: keep in the original vial or ampoule and protect from moisture.

Papaverine can interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid): - Nitrates: Combined use may cause profound hypotension. - Alpha‑blockers: May lead to additive blood‑pressure lowering effects. - Other phosphodiesterase inhibitors: Heightened risk of severe vasodilation.

Moderate Interactions (Monitor Closely): - Antihypertensives: May require dose adjustment. - Anticoagulants: Potential for increased bleeding if vascular integrity is compromised. - CYP450‑modulating drugs: May affect papaverine metabolism and plasma levels.